The Irreproduciblity crisis in the biomedical literature threatens to undermine trust in the scientific enterprise. Analyses performed in the pharmaceutical industry estimate that 80-90% of the published biomedical literature cannot be independently reproduced. This problem is magnified by the fact that we produce over a million new biomedical research papers a year. Hive Scientific addresses this problem through (1) the construction of a comprehensive knowledge network of all empirical findings  through crowdsourcing, and (2) the development of objective confidence metrics that enable scientists, funding agencies, and pharmaceutical companies to distinguish between robust and weak science.